| 中文关键词: 健康中国 分子科学 分子医学 新冠病毒检测 |
| 英文关键词:Healthy China molecular science molecular medicine 2019?鄄nCoV detection |
| 基金项目: |
|
| 摘要点击次数: 997 |
| 全文下载次数: 196 |
| 中文摘要: |
| 摘 要：“健康中国”战略是我国的基本国策，是促进我国卫生健康事业发展和提升人民健康水平的重要抓手，是推动我国医疗健康产业发展的重要引擎。以科技创新引领卫生健康事业发展，推动“健康中国”建设是科技工作者义不容辞的责任。现代医学已经进入分子医学时代，需要从分子水平去了解疾病发生、发展的过程和机制，从分子水平对疾病进行诊断和治疗，以及从分子水平预防预测疾病的发生。分子医学与分子科学、分子生物学相辅相生，发展分子医学依赖于分子科学家不断向生命健康领域深度进军。全文从我国医疗现状出发，阐述了发展分子医学的必要性，并以新冠病毒检测和生物医药研发的两个应用案例，介绍本研究团队在发展分子医学，造福人类健康上做出的探索。 |
| 英文摘要: |
| Abstract：Healthy China is one of China’s national fundamental strategies. It is an important starting point for promoting China’s healthcare cause and improving its people’s health，as well as an important engine for the development of the medical and health industry. Scientific and technical workers are duty-bound to lead the development of health undertakings through technology innovation while promoting the Healthy China Initiative. Modern medicine has entered the era of molecular medicine. It is necessary to understand the cause and process of the disease，to diagnose and treat the disease，to prevent and predict the disease from the molecular level. Molecular medicine is complementary to molecular science and molecular biology. The development of molecular medicine depends on molecular scientists moving ever deeper into the intersection of life and health. This paper expounds the necessity of developing molecular medicine from the current medical situation in China; and also introduces the applications of molecular medicine in the detection of 2019-nCoV and biomedical research，and development accomplished by our team. |
|
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |
